Corcept Therapeutics Inc CORT Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	583.43M	617.85M	524.63M	594.02M	621.52M	655.94M	714.56M	784.26M
Total Current Assets	499.25M	533.89M	432.59M	431.53M	458.64M	503.37M	560.85M	466.98M
Cash and Equivalents	66.33M	299.94M	172.38M	111.8M	135.55M	149.75M	128.59M	137.29M
Total Non-Current Assets	84.81M	84.42M	92.45M	162.5M	162.88M	152.57M	153.71M	317.28M
Total Liabilities	81.59M	88.26M	103.01M	132.34M	114.81M	108.07M	118.31M	145.42M
Total Current Liabilities	72.49M	78.87M	93.06M	121.87M	104.51M	97.2M	100.75M	126.22M
Total Non-Current Liabilities	9.1M	9.4M	9.95M	10.47M	10.31M	10.87M	17.56M	19.21M
Common Equity	131k	131k	132k	133k	133k	133k	134k	135k
Retained Earnings	296.39M	312.27M	339.79M	371.17M	402.53M	430.29M	465.78M	512.99M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	68.75M	220.54M	311.69M	412.31M	571.73M	423.76M	583.43M	621.52M
Total Current Assets	65.69M	124.19M	236.82M	307.36M	478.5M	266.46M	499.25M	458.64M
Cash and Equivalents	51.54M	31.06M	41.63M	31.27M	76.19M	77.62M	66.33M	135.55M
Total Non-Current Assets	41.38M	190.97M	275.88M	371.18M	523.34M	375.81M	501.84M	506.71M
Total Liabilities	27.37M	29.57M	35.81M	41.13M	48.39M	47.95M	81.59M	114.81M
Total Current Liabilities	27.37M	29.57M	35.57M	38.84M	47.49M	47.54M	72.49M	104.51M
Total Non-Current Liabilities	0	0	239k	2.29M	899k	409k	9.1M	10.31M
Total Equity	41.38M	190.97M	275.88M	371.18M	523.34M	375.81M	501.84M	506.71M
Common Equity	113k	115k	117k	120k	122k	127k	131k	133k
Retained Earnings	-322.27M	-193.15M	-117.74M	-23.56M	82.46M	194.97M	296.39M	402.53M